Stifel raised the firm’s price target on Thermo Fisher to $595 from $530 and keeps a Buy rating on the shares. The company’s finish to the year was “generally as expected,” with organic revenue in line and EPS a few cents above, the analyst tells investors. Within the core tools space, the firm prefers Thermo Fisher because it offers a mix of consumables rebound potential, instrument demand stability, beatable expectations, and approachable valuation, Stifel says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher Scientific Reports Earnings: Did it Beat Estimate Forecasts?
- Thermo Fisher (NYSE:TMO) Drops despite Exceeding Q4 Estimates
- Options Volatility and Implied Earnings Moves Today, January 31, 2024
- Thermo Fisher sees FY24 adjusted EPS $20.95-$22.00, consensus $22.04
- Thermo Fisher reports Q4 adjusted EPS $5.67, consensus $5.64